RUCAPARIB for Endometrial cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where RUCAPARIB was used for Endometrial cancer.
Most Reported Side Effects for RUCAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 49 | 11.3% | 2 | 37 |
| Acute kidney injury | 34 | 7.8% | 6 | 34 |
| Febrile neutropenia | 33 | 7.6% | 2 | 33 |
| Fatigue | 32 | 7.4% | 1 | 10 |
| Nausea | 30 | 6.9% | 0 | 15 |
| Pancytopenia | 27 | 6.2% | 2 | 24 |
| Diarrhoea | 23 | 5.3% | 1 | 18 |
| Drug ineffective | 22 | 5.1% | 6 | 1 |
| Vomiting | 20 | 4.6% | 0 | 16 |
| Abdominal pain | 17 | 3.9% | 0 | 15 |
| Thrombocytopenia | 17 | 3.9% | 4 | 12 |
| Constipation | 15 | 3.5% | 0 | 5 |
| Malignant neoplasm progression | 15 | 3.5% | 8 | 6 |
| Pyrexia | 13 | 3.0% | 0 | 11 |
| Decreased appetite | 12 | 2.8% | 0 | 3 |
Other Indications for RUCAPARIB
Ovarian cancer (201)
Prostate cancer metastatic (34)
Small cell lung cancer (29)
Hormone-refractory prostate cancer (27)
Prostate cancer (27)
Neoplasm (13)
Product used for unknown indication (12)
Fallopian tube cancer (9)
Neoplasm malignant (9)
Malignant peritoneal neoplasm (7)
Other Drugs Used for Endometrial cancer
LENVATINIB (6,770)
PEMBROLIZUMAB (4,343)
PACLITAXEL (1,023)
CARBOPLATIN (912)
DOSTARLIMAB (315)
BEVACIZUMAB (276)
DOSTARLIMAB-GXLY (191)
NIRAPARIB (181)
DOXORUBICIN (165)
CISPLATIN (158)